6-Mercaptopurine: Cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts
- 6 April 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (7) , 1455-1463
- https://doi.org/10.1016/0006-2952(93)90045-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumorsCancer Chemotherapy and Pharmacology, 1990
- Effects of methotrexate on purine and pyrimidine metabolism and cell-kinetic parameters in human malignant lymphoblasts of different lineagesBiochemical Pharmacology, 1988
- Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineagesBiochemical Pharmacology, 1988
- Dose-related effects of methotrexate on purine and pyrimidine nucleotides and on cell-kinetic parameters in molt-4 malignant human T-lymphoblastsBiochemical Pharmacology, 1986
- Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblastsBiochemical Pharmacology, 1986
- Consequences of inhibition of purine biosynthesis de novo by 6-methylmercaptopurine ribonucleoside in cultured lymphoma L5178Y cellsPublished by Elsevier ,1978
- 2 The Biochemical Basis for the Drug Actions of PurinesProgress in Medicinal Chemistry, 1970
- Inhibition of phosphoribosyl pyrophosphate amidotransferase from Ehrlich ascites-tumour cells by thiopurine nucleotidesBiochemical Pharmacology, 1969
- Activity and Mechanism of Action of 6-Methylthiopurine Ribonucleoside in Cancer Cells Resistant to 6-MercaptopurineNature, 1965
- Studies on Condensed Pyrimidine Systems. IX. The Synthesis of Some 6-Substituted PurinesJournal of the American Chemical Society, 1952